Agilent Technologies, Inc. (A)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Agilent Technologies, Inc. (A)
Go deeper and ask any question about A
Company Performance
Current Price
as of Sep 13, 2024$137.31
P/E Ratio
28.46
Market Cap
$39.45B
Description
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
Metrics
Overview
- HQSanta Clara, CA
- SectorCommercial Services
- IndustryMiscellaneous Commercial Services
- TickerA
- Price$137.31+0.67%
Trading Information
- Market Cap$39.45B
- Float99.60%
- Average Daily Volume (1m)1,491,287
- Average Daily Volume (3m)1,862,595
- EPS$4.84
Company
- Revenue$6.50B
- Rev Growth (1yr)-5.62%
- Net Income$282.00M
- Gross Margin55.01%
- EBITDA Margin29.66%
- EBITDA$468.00M
- EV$42.30B
- EV/Revenue6.51
- P/E28.46
- P/S6.15